Oral Anticoagulation Therapy and Progression of Calcific Aortic Valve Stenosis

Exclusion criteria were history of rheumatic valve disease, endocarditis, more than mild mitral stenosis, severe mitral/aortic regurgitation, left ventricular ejection fraction

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the American College of Cardiology 2019-04, Vol.73 (14), p.1869-1871
Hauptverfasser:	Tastet, Lionel, Pibarot, Philippe, Shen, Mylène, Clisson, Marine, Côté, Nancy, Salaun, Erwan, Arsenault, Marie, Bédard, Élisabeth, Capoulade, Romain, Puri, Rishi, Poirier, Paul, Clavel, Marie-Annick
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Angiotensin Anticoagulants Anticoagulants - administration & dosage Anticoagulants - adverse effects Anticoagulants - classification Aortic valve Aortic Valve - pathology Aortic Valve Stenosis - diagnosis Aortic Valve Stenosis - drug therapy Aortic Valve Stenosis - physiopathology Body mass Body mass index Body size Calcinosis - diagnosis Calcinosis - drug therapy Cardiac arrhythmia Cardiology Cardiovascular disease Chronic obstructive pulmonary disease Coronary artery Coronary artery disease Creatinine Diabetes Diabetes mellitus Disease Progression Echocardiography Echocardiography - methods Endocarditis Factor Xa Inhibitors - administration & dosage Factor Xa Inhibitors - adverse effects Female Follow-Up Studies Heart Heart diseases Humans Hypertension Male Middle Aged Pharmacovigilance Regression analysis Regurgitation Renin Smoking Statins Stenosis Therapy Vascular diseases Ventricle Warfarin Warfarin - administration & dosage Warfarin - adverse effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Exclusion criteria were history of rheumatic valve disease, endocarditis, more than mild mitral stenosis, severe mitral/aortic regurgitation, left ventricular ejection fraction
ISSN:	0735-1097 1558-3597
DOI:	10.1016/j.jacc.2019.01.043